Dyadic International Inc (DYAI)
Sector • Healthcare Industry • Biotechnology & Pharmaceuticals |
Industry • Biotechnology & Pharmaceuticals |
Sector • Healthcare |
News
Dyadic International Announces Changes in Board and Achieves Record-breaking ROI in Q3 2023
Dyadic Announces $60 Million Private Placement to Drive Revenue Growth and Commercialization Efforts
Dyadic*s Cutting-Edge Collaboration Set to Uphold Recombinant Protein Production
Dyadic International Inc. Experiences Sharp Contraction in Financial Performance as of Sep 30, 2023
Dyadic International Inc*s First Quarter of 2023 Reveals Unexpected and Shocking Revenue Plunge
Looking into fourth quarter of 2022 effort, the Biotechnology & Pharmaceuticals company*s had